Show Caption

President Donald Trump will announce the launch of the TrumpRx website on Feb. 5, which is designed to offer medications at lower prices, part of his administration’s effort to lower drug to levels paid by other developed countries. 

The prices would reflect discounts the White House said it has negotiated with more than a dozen drug companies including Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi under the “most favored nation” drug pricing deals.

White House Press Secretary Karoline Leavitt urged people to tune in at 7 p.m.

“President Trump, Dr. Oz, and National Design Studio Director Joe Gebbia will be officially unveiling TrumpRx — a state of the art website for Americans consumers to purchase low cost prescription drugs,” she wrote on X. “This historic announcement will save millions of Americans money. You won’t want to miss it!”

In a series of Oval Office announcements in 2025, Trump touted more than a dozen deals with pharmaceutical industry giants to sell discounted medications to Medicaid or TrumpRx.

In each of the deals, the Trump administration agreed to forego planned pharmaceutical industry tariffs in exchange for the drug companies selling products at discounted prices to Medicaid and direct to consumers via TrumpRx.

Pfizer, the first company to announce the deal on Sept. 30,  said the program would allow patients to buy Pfizer drugs at a discount of 50% on average. The company, in a news release, also said it would include the majority of the company’s primary care treatments and some specialty brands.

“By taking this bold step, we’re ending the era of global price-gouging at the expense of American families and we’re making America healthy again,” Trump said of Pfizer’s move.

Trump has said the companies agreed to sell prescription drugs at prices that are no greater than those of comparable countries. The agreement follows an executive order Trump signed in March that instituted a “most favored nation” policy for drug pricing.

Trump announced the first deal with Pfizer on Sept. 30 and followed with October, November and December announcements with more than a dozen other companies.

In November, Trump announced deals with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs Wegovy and Zepbound and expand Medicare coverage of these medications for older adults.

On Dec. 19, Trump announced “most favored nation” drug pricing deals with Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi.

Who will use TrumpRx?

Most working-age Americans get health insurance and prescription drug coverage from their employer. Consumers who buy Affordable Care Act insurance – as well as older adults and low-income families enrolled in government health insurance programs Medicare and Medicaid – typically get drug discounts through their insurance plans.

Uninsured Americans, however, often must pay for prescription medications with their own money.

Consumer websites such as GoodRx and entrepreneur Mark Cuban’s Cost Plus Drugs offer discounted prescription drugs to consumers

Novo Nordisk and Eli Lilly sell popular weight-loss medications through their own pharmacies, chain retailers and discount websites. Consumers need prescriptions from a health care provider to purchase the drugs.